首页> 外文期刊>Journal of the American Chemical Society >Uracil-Directed Ligand Tethering:An Efficient Strategy for Uracil DNA Glycosylase(UNG)Inhibitor Development
【24h】

Uracil-Directed Ligand Tethering:An Efficient Strategy for Uracil DNA Glycosylase(UNG)Inhibitor Development

机译:尿嘧啶指导配体束缚:尿嘧啶DNA糖基化酶(UNG)抑制剂发展的有效策略。

获取原文
获取原文并翻译 | 示例
       

摘要

Uracil DNA glycosylase(UNG)is an important DNA repair enzyme that recognizes and excises uracil bases in DNA using an extrahelical recognition mechanism.It is emerging as a desirable target for small-molecule inhibitors given its key role in a wide range of biological processes including the generation of antibody diversity,DNA replication in a number of viruses,and the formation of DNA strand breaks during anticancer drug therapy.To accelerate the discovery of inhibitors of UNG we have developed a uracil-directed ligand tethering strategy.In this efficient approach,a uracil aldehyde ligand is tethered via alkyloxyamine linker chemistry to a diverse array of aldehyde binding elements.Thus,the mechanism of extrahelical recognition of the uracil ligand is exploited to target the UNG active site,and alkyloxyamine linker tethering is used to randomly explore peripheral binding pockets.Since no compound purification is required,this approach rapidly identified the first small-molecule inhibitors of human UNG with micromolar to submicromolar binding affinities.In a surprising result,these uracil-based ligands are found not only to bind to the active site but also to bind to a second uncompetitive site.The weaker uncompetitive site suggests the existence of a transient binding site for uracil during the multistep extrahelical recognition mechanism.This very general inhibitor design strategy can be easily adapted to target other enzymes that recognize nucleobases,including other DNA repair enzymes that recognize other types of extrahelical DNA bases.
机译:尿嘧啶DNA糖基化酶(UNG)是一种重要的DNA修复酶,可利用螺旋外识别机制识别和切除DNA中的尿嘧啶碱基,由于其在广泛的生物过程中起关键作用,因此正在成为小分子抑制剂的理想靶标。在抗癌药物治疗过程中,抗体多样性的产生,DNA在多种病毒中的复制以及DNA链断裂的形成。为了加快UNG抑制剂的发现,我们开发了尿嘧啶导向的配体束缚策略。在这种有效方法中,通过烷氧基胺接头化学将一个尿嘧啶醛配体束缚到各种各样的醛结合元件上。因此,利用尿嘧啶配体的螺旋外识别机制靶向UNG活性位点,并使用烷氧基胺接头束缚随机探索外围结合由于不需要化合物纯化,该方法可快速鉴定出第一个小分子抑制剂令人惊讶的结果是,发现这些基于尿嘧啶的配体不仅与活性位点结合,而且还与第二个非竞争性位点结合。较弱的非竞争性位点表明存在在多步螺旋外识别机制中尿嘧啶的瞬时结合位点。这种非常通用的抑制剂设计策略可以轻松地针对靶向识别核碱基的其他酶,包括识别其他类型螺旋外DNA碱基的其他DNA修复酶。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2005年第49期|p.17412-17420|共9页
  • 作者单位

    Contribution from the Department of Pharmacology and Molecular Sciences,Johns Hopkins University School of Medicine,725 North Wolfe Street,Baltimore,Maryland 21205;

    Contribution from the Department of Pharmacology and Molecular Sciences,Johns Hopkins University School of Medicine,725 North Wolfe Street,Baltimore,Maryland 21205;

    Contribution from the Department of Pharmacology and Molecular Sciences,Johns Hopkins University School of Medicine,725 North Wolfe Street,Baltimore,Maryland 21205;

    Contribution from the Department of Pharmacology and Molecular Sciences,Johns Hopkins University School of Medicine,725 North Wolfe Street,Baltimore,Maryland 21205;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

  • 入库时间 2022-08-18 03:24:21

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号